Impaired Endothelial Integrity in Patients With Embolic Stroke of Undetermined Source (ESUS) (ESUS)
Impaired Endothelial Glycocalyx Integrity and Arterial Elastic Properties in Patients With Embolic Stroke of Undetermined Source (ESUS)
Sponsor: University of Athens
Listed as NCT03609437, this observational or N/A phase trial focuses on Embolic Stroke of Undetermined Source and Endothelial Dysfunction and remains ongoing. Sponsored by University of Athens, it has been updated 7 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Aug 2025 — Present [monthly]
Active Not Recruiting
Status: Completed → Active Not Recruiting
-
Sep 2024 — Aug 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
▶ Show 2 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Aug 2018 — Nov 2020 [monthly]
Completed
First recorded
Jan 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Athens
For direct contact, visit the study record on ClinicalTrials.gov .